A leading indicator for stocks just entered a death cross, but the ominous signal might not be as scary as it's cracked up to be.
The two sneaker stocks could face bigger hurdles when they report next week.
Signs of euphoria are creeping into the market, and that's giving one trader déjà vu.
Apple shares have fallen more than 5 percent from its recent high, but one technician says investors shouldn't worry just yet.
Stocks look solid on the surface but a deeper look shows signs the market is starting to crack.
The nearly decadelong bull market in the U.S. is long in the tooth and there are better gains to be had elsewhere, says one strategist.
Amgen is up nearly 100,000% since 1984, but Carter Worth of Cornerstone Macro says the rally is just getting started.
Biotech looks ripe for a breakout, and one top technician says there are two prime reasons to buy now.
David Stockman has a stern message for investors: You're living in a fantasy land about President Trump.
After years of calling for a correction that has yet to happen, the so-called Dr. Doom found himself under fire from a trader.